Paris – Now organised by ESMO, the International Congress on Targeted Anticancer Therapies will be held on an annual basis in Europe.

5-7 March 2018

TAT focuses on early-phase development and translational research. The programme will cover targeted agents, immuno-oncology and combinations involving such agents.

All useful information